Gene · 3817
Papers1,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ionic Mechanisms of Propagated Repolarization in a One-Dimensional Strand of Human Ventricular Myocyte Model. | Int J Mol Sci | 2023 | 37895058 | PubTator, text mining | PubMed |
| MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs. | Sci Rep | 2023 | 37880276 | PubTator, text mining | PubMed |
YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy. | Front Pharmacol | 2023 | 37860121 | PubTator, text mining | PubMed |
| Prognostic analyses of genes associated with anoikis in breast cancer. | PeerJ | 2023 | 37842046 | PubTator, text mining | PubMed |
| Antagonism of androgen receptor signaling by aloe-emodin. | Food Chem Toxicol | 2023 | 37806336 | PubTator, text mining | PubMed |
| Compartmentalization of androgen receptors at endogenous genes in living cells. | Nucleic Acids Res | 2023 | 37791849 | PubTator, text mining | PubMed |
| Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures. | Mol Cancer | 2023 | 37789377 | PubTator, text mining | PubMed |
| Emerging Immunotherapy Approaches for Treating Prostate Cancer. | Int J Mol Sci | 2023 | 37762648 | PubTator, text mining | PubMed |
| Non-Canonical Amino Acids in Analyses of Protease Structure and Function. | Int J Mol Sci | 2023 | 37762340 | PubTator, text mining | PubMed |
| Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer. | Cells | 2023 | 37759434 | PubTator, text mining | PubMed |
| The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer. | J Clin Invest | 2023 | 37751307 | PubTator, text mining | PubMed |
| Deoxynortryptoquivaline: A unique antiprostate cancer agent. | Oncol Res | 2023 | 37744273 | PubTator, text mining | PubMed |
| Recent advances and future perspectives in the therapeutics of prostate cancer. | Exp Hematol Oncol | 2023 | 37740236 | PubTator, text mining | PubMed |
| Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies. | Br J Cancer | 2023 | 37740039 | PubTator, text mining | PubMed |
| Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach. | Cell Rep Med | 2023 | 37738978 | PubTator, text mining | PubMed |
| A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data. | Ann Med | 2023 | 37729607 | PubTator, text mining | PubMed |
| Mutational signatures and their association with survival and gene expression in urological carcinomas. | Neoplasia | 2023 | 37678146 | PubTator, text mining | PubMed |
| Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer. | Cancer Discov | 2023 | 37676710 | PubTator, text mining | PubMed |
| Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. | Br J Cancer | 2023 | 37673961 | PubTator, text mining | PubMed |
| Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models. | Nat Commun | 2023 | 37660083 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3817/papers?page=5